HIGHLIGHTS
- who: Yumiko Kawada-Shimamura from the Sapporo, u20118585, Japan have published the research: Biomarker discovery for practice of precision medicine in hypopharyngeal cancer: a theranostic study on response prediction of the key therapeutic agents, in the Journal: (JOURNAL)
- what: The authors ventured to focus on the conventional key cytotoxic drugs still widely used in practice and newly proposed 4 genes (or proteins) as the most powerful exploratory markers for drug response prediction: They are AGR2 and PDE4D for TXT; NINJ2 for CDDP; and CDC25B for 5-FU. All authors have given final approval of the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.